There are a number of important issues regarding neoadjuvant and adjuvant therapy for pancreatic cancer that must be considered as we design clinical trials in an effort to improve survival for this disease.
Vincent Vinciguerra, MD
Advertisement
Articles by Vincent Vinciguerra, MD
Advertisement
Latest Updated Articles
- Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer
February 18th 2011
Advertisement
Advertisement
Trending on CancerNetwork
1
Investigational Radioenhancer Shows Feasibility in Stage III NSCLC
2
Alpha DaRT Overcomes Anatomical Constraints in Inoperable Pancreatic Cancer
3
Mechanistic and Translational Insights of CARv3-TEAM-E in Glioblastoma
4
101 Patient-Reported Outcomes (PROs) in Patients With ER+, HER2- Advanced Breast Cancer (ABC) Treated with Imlunestrant, Investigator’s Choice Standard Endocrine Therapy, or Imlunestrant+Abemaciclib: Results From the Phase III EMBER-3 Trial
5